In parallel, both tumor cells and immunosuppressive myeloid populations, such as MDSCs, highly express indoleamine 2,3-dioxygenase (IDO), which catalyzes the degradation of tryptophan into immunosuppressive metabolites like kynurenine (101). This evidence concerns the gene IDO1 and neoplasm.